The impact of fibroblast growth factor-23 on the cardiovascular system in chronic kidney disease
{{output}}
Chronic kidney disease is associated with an accelerated risk of cardiovascular (CV) mortality. Seminal work over the last decade has identified abnormal bone metabolism as an important modulator of the increased CV burden in this cohort. In particular, FGF23,... ...
